Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Concor COR

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

59 API Suppliers, 15 USDMF, 19 CEP/COS, 8 JDMF, 12 EU WC, 5 KDMF, 12 NDC API, 41 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

725 FDF Dossiers, 69 FDA Orange Book, 382 Europe, 22 Canada, 42 Australia, 68 South Africa, 142 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 5 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 14 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 27 Direct Compression, 20 Thickeners and Stabilizers, 20 Controlled & Modified Release, 19 Granulation, 17 Disintegrants & Superdisintegrants, 17 Solubilizers, 14 Topical, 13 Lubricants & Glidants, 13 Film Formers & Plasticizers, 11 Co-Processed Excipients, 10 Taste Masking, 7 Chewable & Orodispersible Aids, 7 Parenteral, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents

DIGITAL CONTENT

22 News #PharmaBuzz

22 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 246 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

31 APIs, 22 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 15 Others

ANALYTICAL

4 BioAnalytical Methods

4 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Ipca Laboratories	India	Agerson Bio Co., Ltd.	20210226-209-J-528(1)	bisoprolol fumarate	2025-03-18	IPCA Laboratories Limited	India	PO Sejavta, District-Ratlam (MP) 457001, India
29/11/2025	Ipca Laboratories	India	Sungjin Exim Co., Ltd.	20210226-209-J-528	bisoprolol fumarate	2021-02-26	IPCA Laboratories Limited	India	PO Sejavta, District-Ratlam (MP) 457001, India

Concor COR

Concor COR

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

59 API Suppliers

15 USDMF

19 CEP/COS

8 JDMF

12 EU WC

5 KDMF

12 NDC API

41 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

24 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

725 FDF Dossiers

69 FDA Orange Book

382 Europe

22 Canada

42 Australia

68 South Africa

142 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

5 DKSH

2 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Kirsch Pharma

1 ACG Worldwide

5 Actylis

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

16 BASF

1 Clariant

10 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

1 Finar

10 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

4 Ideal Cures

3 Ingredion Pharma Solutions

14 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

10 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

13 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives

42 Fillers, Diluents & Binders

27 Direct Compression

20 Thickeners and Stabilizers

20 Controlled & Modified Release

19 Granulation

TABLET;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons